BioSig Technologies, Inc. announces its intention to offer shares of common stock through an underwritten public offering.
The net proceeds will be used to purchase gold bullion, working capital, and general corporate purposes.
Clear Street and Needham & Company are the joint book-running managers of the offering.
Offering Details
Shares of common stock will be offered through an underwritten public offering. Proceeds to be used for gold bullion, working capital, and corporate purposes.
Book-Running Managers
Clear Street and Needham & Company are acting as joint book-running managers of the offering.
Registration Statement
The offering is being made pursuant to a shelf registration statement on Form S-3, declared effective by the SEC on December 17, 2024.
- The offering signals BioSig's strategic move to raise capital for specific investment purposes.
- By involving reputable book-running managers, BioSig aims to secure a successful offering.
- The completion of the offering is subject to market conditions, highlighting the flexibility required in fundraising endeavors.
BioSig Technologies' proposed public offering reflects its forward-looking approach to financing and strategic growth in the market.